Mind Medicine (MNMD) has released an update.
Mind Medicine (MindMed) Inc., a biopharmaceutical company focusing on treatments for brain health disorders, will be presenting at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference. The event, which showcases MindMed’s latest developments, will be available via webcast on their Investor Relations website starting June 27, 2024, with a replay option for 90 days.
For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.
